1.54
+0.03(+1.99%)
Currency In USD
| Previous Close | 1.51 |
| Open | 1.52 |
| Day High | 1.54 |
| Day Low | 1.5 |
| 52-Week High | 30.48 |
| 52-Week Low | 1.44 |
| Volume | 17,047 |
| Average Volume | 352,366 |
| Market Cap | 873,882 |
| PE | 0 |
| EPS | -1,268.49 |
| Moving Average 50 Days | 3.45 |
| Moving Average 200 Days | 5.82 |
| Change | 0.03 |
If you invested $1000 in GlucoTrack, Inc. (GCTK) 10 years ago, it would be worth $0 as of February 24, 2026 at a share price of $1.54. Whereas If you bought $1000 worth of GlucoTrack, Inc. (GCTK) shares 5 years ago, it would be worth $0.06 as of February 24, 2026 at a share price of $1.54.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Glucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform
GlobeNewswire Inc.
Jan 29, 2026 1:01 PM GMT
RUTHERFORD, N.J., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc.(“Glucotrack”, or the “Company”) (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes,
Glucotrack, Inc. Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor
GlobeNewswire Inc.
Dec 30, 2025 1:00 PM GMT
Rutherford, NJ., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (the “Company”), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announc
Glucotrack, Inc. Encourages Shareholders to Vote
GlobeNewswire Inc.
Nov 03, 2025 9:05 PM GMT
The Special Meeting of Shareholders reconvenes on November 7, 2025 Shareholders vote on Equity Purchase Agreement with Sixth Borough Capital Fund RUTHERFORD, N.J., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or t